Search Results - "Capdevila J"

Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.

Authors: Baudin, E. Capdevila, J. Hörsch, D. et al.

Source: Endocrine-Related Cancer. Sep2024, Vol. 31 Issue 9, p1-12. 12p.

1710MO Belzutifan for advanced pancreatic neuroendocrine tumors (panNETs): Results from cohort A2 of the phase II LITESPARK-015 study.

Authors: Capdevila, J. Artamonova, E. de Jesus Acosta, A. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1008-S1009. 2p.

Development of the ZOE diet score, and associations with dietary diversity.

Authors: Creedon, AC. Capdevila, J. Wallace, M. et al.

Source: Proceedings of the Nutrition Society. Nov2025, Vol. 84 Issue OCE5, p1-1. 1p.

1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden.

Authors: Singh, S. Capdevila, J. Halfdanarson, T.R. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1020-S1020. 1p.

1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial.

Authors: Capdevila, J. Amthauer, H. Ansquer, C. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1006-S1006. 1p.

ASPECTOS PRÁCTICOS Y CONSIDERACIONES SOBRE PELIGROS MICROBIOLÓGICOS Y QUÍMICOS EN EL USO SISTEMA LACTOPEROXIDASA EN EL TRÓPICO AMERICANO.

Alternate Title: PRACTICAL ASPECTS AND CONSIDERATIONS ABOUT MICROBIOLOGICAL AND CHEMICAL RISKS IN THE USE OF THE LACTOPEROXIDASE SYSTEM IN THE AMERICAN TROPIC.

Authors: Ponce, P. Capdevila, J. Z. Armenteros, Mabelin

Source: Revista de Salud Animal. sep2004, Vol. 26 Issue 3, p163-172. 10p.

Encuesta multicéntrica nacional sobre el manejo de la infección en pacientes alérgicos a betalactàmicos.

Alternate Title: Multicenter national survey on infection management in patients with penicillin allergy.

Authors: Serrano, R. Capdevila, J. A. Mensa, J. et al.

Source: Revista Española de Quimioterapia. 2009, Vol. 22 Issue 1, p10-19. 10p. 2 Charts, 4 Graphs.

Subjects: DRUG allergy, PENICILLIN, QUINOLONE antibacterial agents, BETA lactam antibiotics, GLYCOPEPTIDES, MACROLIDE antibiotics, ANTIBACTERIAL agents, INTERNAL medicine

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Authors: Capdevila, J Mayor, R Mancuso, F M et al.

Source: Annals of Oncology. Jun2018, Vol. 29 Issue 6, p1454-1460. 7p. 3 Diagrams, 1 Graph.

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation.

Authors: Knigge, U. Capdevila, J. Bartsch, D.K. et al.

Source: Neuroendocrinology. Sep2017, Vol. 105 Issue 3, p310-319. 10p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The right compound for the right target: tackling RET.

Authors: Seoane, J Capdevila, J

Source: Annals of Oncology. Aug2018, Vol. 29 Issue 8, p1623-1625. 3p. 1 Diagram, 1 Chart.

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).

Authors: Grande, E. Capdevila, J. Castellano, D. et al.

Source: Annals of Oncology. Sep2015, Vol. 26 Issue 9, p1987-1993. 7p. 2 Charts, 2 Graphs.

This result is not displayed to guests.
Login for full access.

Biotherapy for neuroendocrine tumours.

Authors: Alonso-Gordoa, T. Capdevila, J. Grande, E.

Source: European Journal of Endocrinology. Jan2015, Vol. 172 Issue 1, pR31-R46. 16p.